Philippe Couvert a, b, c, Alain Carrié a, b, c, Sophie Tezenas du Montcel d, Jenny Vaysse e, Angela Sutton e, Nathalie Barget f, g, Jean-Claude Trinchet f, g, Michel Beaugrand f, g, Nathalie Ganne f, ⁎, g , Philippe Giral a, b, h, Jamel Chelly i, j
a Inserm U939, Dyslipidemia, Inflammation and Atherosclerosis in metabolic diseases, 75013 Paris, France
b Pierre and Marie Curie University – Paris 6, UMRS 939, 75013 Paris, France
c AP–HP, Pitié-Salpétrière Hospital, Endocrine and oncological Biochemistry, 75651 Paris 13, France
d AP–HP, Pitié-Salpétrière Hospital, Clinical Research Unit, 75651 Paris 13, France
e AP–HP, Jean-Verdier Hospital, Biochemistry laboratory, 93143 Bondy, France
f AP–HP, Jean-Verdier Hospital, Hepato-gastroenterology Unit, 93143 Bondy, France
g UPRES EA 3409, Paris 13 University, France
h AP–HP, Pitié-Salpétrière Hospital, Endocrinology-Metabolism Unit, 75651 Paris 13, France
i Inserm U1016, Genetics and pathophysiology of neurodevelopmental and neuromuscular diseases, 75014 Paris, France
j AP–HP, Cochin-Saint Vincent de Paul Hospital, Biochimistry and molecular genetics laboratory, 75014, France